ImportRefusal LogoImportRefusal

CAPITAINE NAT

⚠️ High Risk

FEI: 3025876721 • Pia, Pyrenees-Orientales • FRANCE

FEI

FEI Number

3025876721

📍

Location

Pia, Pyrenees-Orientales

🇫🇷

Country

FRANCE
🏢

Address

27 Chemin De Las Nougueres, , Pia, Pyrenees-Orientales, France

High Risk

FDA Import Risk Assessment

51.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

10
Total Refusals
6
Unique Violations
5/4/2023
Latest Refusal
2/13/2023
Earliest Refusal

Score Breakdown

Violation Severity
51.1×40%
Refusal Volume
38.6×30%
Recency
46.2×20%
Frequency
100.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

8310×

NO PROCESS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the manufacturer's failure to file a scheduled process demonstrates that the product is not being manufactured under the mandatory provisions of 21 CFR Part 108 and therefore appears to have been manufactured, processed, or packed, under insanitary conditions whereby it may have been rendered injurious to health.

3216×

LACKS N/C

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.

3246×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

4826×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

4734×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

824×

RX LEGEND

The article appears to be a prescription drug without a prescription drug legend as required by Section 503(b)(4).

Refusal History

DateProductViolationsDivision
5/4/2023
16XEY03SALMON, ALL, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS
321LACKS N/C
324NO ENGLISH
482NUTRIT LBL
83NO PROCESS
Division of Southeast Imports (DSEI)
5/4/2023
16AYY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
321LACKS N/C
324NO ENGLISH
482NUTRIT LBL
83NO PROCESS
Division of Southeast Imports (DSEI)
5/4/2023
16AYY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
321LACKS N/C
324NO ENGLISH
482NUTRIT LBL
83NO PROCESS
Division of Southeast Imports (DSEI)
5/4/2023
16AYY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
321LACKS N/C
324NO ENGLISH
482NUTRIT LBL
83NO PROCESS
Division of Southeast Imports (DSEI)
5/4/2023
16AYY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
321LACKS N/C
324NO ENGLISH
482NUTRIT LBL
83NO PROCESS
Division of Southeast Imports (DSEI)
5/4/2023
16AYY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
321LACKS N/C
324NO ENGLISH
482NUTRIT LBL
83NO PROCESS
Division of Southeast Imports (DSEI)
2/13/2023
16AMY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
473LABELING
82RX LEGEND
83NO PROCESS
Division of Southeast Imports (DSEI)
2/13/2023
16AMY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
473LABELING
82RX LEGEND
83NO PROCESS
Division of Southeast Imports (DSEI)
2/13/2023
16AEY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
473LABELING
82RX LEGEND
83NO PROCESS
Division of Southeast Imports (DSEI)
2/13/2023
16AMY33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.)
473LABELING
82RX LEGEND
83NO PROCESS
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is CAPITAINE NAT's FDA import refusal history?

CAPITAINE NAT (FEI: 3025876721) has 10 FDA import refusal record(s) in our database, spanning from 2/13/2023 to 5/4/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CAPITAINE NAT's FEI number is 3025876721.

What types of violations has CAPITAINE NAT received?

CAPITAINE NAT has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CAPITAINE NAT come from?

All FDA import refusal data for CAPITAINE NAT is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.